News >

CA-125 Monitoring Shows Benefit in Early Detection of Ovarian Cancer

Ben Leach
Published: Monday, Aug 26, 2013

Dr. Karen H. Lu

Karen H. Lu, MD

A two-pronged approach that includes carbohydrate antigen 125 (CA-125) testing proved highly accurate in screening women for ovarian cancer, including aggressive forms of the disease, according to updated results of an 11-year study aimed at providing a strategy for early detection.

Lu KH, Skates S, Hernandez MA, et al. A 2-stage ovarian cancer screening strategy using the risk of ovarian cancer algorithm (ROCA) identifies early-stage incident cancers and demonstrates high positive predictive value [published online ahead of print August 26, 2013]. Cancer. doi:10.1002/cncr.28183.

... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: ASCO Direct™ Highlights – 2019 Official Annual Meeting ReviewAug 30, 20201.5
Community Practice Connections™: Advances in Ovarian Cancer: Evolving Applications for PARP Inhibitors, Immunotherapy & Beyond!Aug 30, 20201.5
Publication Bottom Border
Border Publication
x